Regulation 536/2014 and its beneficial impacts on academic clinical research in Italy. Closing the loop

Regulation (EU) No 536/2014 (Clinical Trial Regulation, CTR) offers two precious tools to academic clinical research in Italy:- The right to transfer not-for-profit clinical trials data and results for registration purposes, and co-sponsorship.- The right to transfer data reduces the time needed to...

Full description

Bibliographic Details
Main Authors: Alessandra Mancino, Enrico Crea, Monica Messina, Marco Ferrante, Maria Valeria Feraco, Paola Fazi, Marco Vignetti
Format: Article
Language:English
Published: Elsevier 2022-10-01
Series:Contemporary Clinical Trials Communications
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2451865422001090
_version_ 1798001159457210368
author Alessandra Mancino
Enrico Crea
Monica Messina
Marco Ferrante
Maria Valeria Feraco
Paola Fazi
Marco Vignetti
author_facet Alessandra Mancino
Enrico Crea
Monica Messina
Marco Ferrante
Maria Valeria Feraco
Paola Fazi
Marco Vignetti
author_sort Alessandra Mancino
collection DOAJ
description Regulation (EU) No 536/2014 (Clinical Trial Regulation, CTR) offers two precious tools to academic clinical research in Italy:- The right to transfer not-for-profit clinical trials data and results for registration purposes, and co-sponsorship.- The right to transfer data reduces the time needed to make innovative therapeutical agents and therapies accessible to the patient.Co-sponsorship, on the other hand, allows the establishment of a partnership between entities with different missions, ideals and attitudes, sharing – nevertheless - the same ultimate goal: meeting the patient's medical needs. Co-sponsorship facilitates collaboration among experts, which allows knowledge sharing, thus guaranteeing, to each contributor, recognition for their own contributions to a complex activity such as a clinical trial.However, the above-mentioned Regulation poses important challenges, especially in terms of infrastructural efficiency, which is demanding, especially for those entities suffering organizational inadequacies: unfortunately, inefficiency is sometimes a structural problem in the academic clinical environment. This publication focuses on the specific innovative aspects introduced by CTR. It also highlights the possible difficulties to be addressed by their implementation.
first_indexed 2024-04-11T11:31:41Z
format Article
id doaj.art-8fb236c3cd414d18a76a85ceb82be01a
institution Directory Open Access Journal
issn 2451-8654
language English
last_indexed 2024-04-11T11:31:41Z
publishDate 2022-10-01
publisher Elsevier
record_format Article
series Contemporary Clinical Trials Communications
spelling doaj.art-8fb236c3cd414d18a76a85ceb82be01a2022-12-22T04:26:06ZengElsevierContemporary Clinical Trials Communications2451-86542022-10-0129100992Regulation 536/2014 and its beneficial impacts on academic clinical research in Italy. Closing the loopAlessandra Mancino0Enrico Crea1Monica Messina2Marco Ferrante3Maria Valeria Feraco4Paola Fazi5Marco Vignetti6Fondazione G.I.M.EM.A.- Franco Mandelli Onlus, Rome, Italy; Corresponding author.Fondazione G.I.M.EM.A.- Franco Mandelli Onlus, Rome, ItalyFondazione G.I.M.EM.A.- Franco Mandelli Onlus, Rome, ItalyStudio Legale FLC, Rome, ItalyStudio Legale FLC, Rome, ItalyFondazione G.I.M.EM.A.- Franco Mandelli Onlus, Rome, ItalyFondazione G.I.M.EM.A.- Franco Mandelli Onlus, Rome, Italy; Department of Translational and Precision Medicine, Hematology, Sapienza University of Rome, Rome, ItalyRegulation (EU) No 536/2014 (Clinical Trial Regulation, CTR) offers two precious tools to academic clinical research in Italy:- The right to transfer not-for-profit clinical trials data and results for registration purposes, and co-sponsorship.- The right to transfer data reduces the time needed to make innovative therapeutical agents and therapies accessible to the patient.Co-sponsorship, on the other hand, allows the establishment of a partnership between entities with different missions, ideals and attitudes, sharing – nevertheless - the same ultimate goal: meeting the patient's medical needs. Co-sponsorship facilitates collaboration among experts, which allows knowledge sharing, thus guaranteeing, to each contributor, recognition for their own contributions to a complex activity such as a clinical trial.However, the above-mentioned Regulation poses important challenges, especially in terms of infrastructural efficiency, which is demanding, especially for those entities suffering organizational inadequacies: unfortunately, inefficiency is sometimes a structural problem in the academic clinical environment. This publication focuses on the specific innovative aspects introduced by CTR. It also highlights the possible difficulties to be addressed by their implementation.http://www.sciencedirect.com/science/article/pii/S2451865422001090Clinical trialsEuropean regulationCo-sponsorshipNot-for-profit clinical trialsAcademic clinical researchLegislation
spellingShingle Alessandra Mancino
Enrico Crea
Monica Messina
Marco Ferrante
Maria Valeria Feraco
Paola Fazi
Marco Vignetti
Regulation 536/2014 and its beneficial impacts on academic clinical research in Italy. Closing the loop
Contemporary Clinical Trials Communications
Clinical trials
European regulation
Co-sponsorship
Not-for-profit clinical trials
Academic clinical research
Legislation
title Regulation 536/2014 and its beneficial impacts on academic clinical research in Italy. Closing the loop
title_full Regulation 536/2014 and its beneficial impacts on academic clinical research in Italy. Closing the loop
title_fullStr Regulation 536/2014 and its beneficial impacts on academic clinical research in Italy. Closing the loop
title_full_unstemmed Regulation 536/2014 and its beneficial impacts on academic clinical research in Italy. Closing the loop
title_short Regulation 536/2014 and its beneficial impacts on academic clinical research in Italy. Closing the loop
title_sort regulation 536 2014 and its beneficial impacts on academic clinical research in italy closing the loop
topic Clinical trials
European regulation
Co-sponsorship
Not-for-profit clinical trials
Academic clinical research
Legislation
url http://www.sciencedirect.com/science/article/pii/S2451865422001090
work_keys_str_mv AT alessandramancino regulation5362014anditsbeneficialimpactsonacademicclinicalresearchinitalyclosingtheloop
AT enricocrea regulation5362014anditsbeneficialimpactsonacademicclinicalresearchinitalyclosingtheloop
AT monicamessina regulation5362014anditsbeneficialimpactsonacademicclinicalresearchinitalyclosingtheloop
AT marcoferrante regulation5362014anditsbeneficialimpactsonacademicclinicalresearchinitalyclosingtheloop
AT mariavaleriaferaco regulation5362014anditsbeneficialimpactsonacademicclinicalresearchinitalyclosingtheloop
AT paolafazi regulation5362014anditsbeneficialimpactsonacademicclinicalresearchinitalyclosingtheloop
AT marcovignetti regulation5362014anditsbeneficialimpactsonacademicclinicalresearchinitalyclosingtheloop